oxamic acid has been researched along with piperidines in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (62.50) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schwab, IR | 1 |
| Hussar, DA | 1 |
| Trayner, EM | 1 |
| Joseph Titi, M | 1 |
| Couturier, C; Goldschmidt, P; Haeffner-Cavaillon, N; Herman, D; Kazatchkine, M | 1 |
| Blondin, C; Cholley, B; Goldschmidt, P; Haeffner-Cavaillon, N | 1 |
| Arai, H; Harada, S; Hashimoto, C; Hirota, Y; Igarashi, T; Matsushita, S; Miura, T; Narumi, T; Nomura, W; Ohashi, N; Otsuki, H; Tamamura, H; Yoshimura, K | 1 |
| Harada, S; Irahara, Y; Matsushita, S; Miura, T; Mizuguchi, T; Mori, H; Narumi, T; Nomura, W; Ohashi, N; Tamamura, H; Yamada, Y; Yoshimura, K | 1 |
1 review(s) available for oxamic acid and piperidines
| Article | Year |
|---|---|
A critical look at ocular allergy drugs.
Topics: Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Conjunctivitis, Allergic; Histamine H1 Antagonists; Humans; Ketorolac Tromethamine; Oxamic Acid; Piperidines; Tolmetin; Tromethamine | 1996 |
7 other study(ies) available for oxamic acid and piperidines
| Article | Year |
|---|---|
Nonsteroidal eye drops for ocular allergy.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Conjunctivitis, Allergic; Drug Combinations; Histamine H1 Antagonists; Humans; Ketorolac Tromethamine; Ophthalmic Solutions; Oxamic Acid; Piperidines; Tolmetin; Tromethamine | 1994 |
New therapeutic agents marketed in 1993.
Topics: Adolescent; Adult; Anti-Ulcer Agents; Child; Cisapride; Cladribine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Approval; Histamine H1 Antagonists; Humans; Nedocromil; Nitriles; Oxamic Acid; Paclitaxel; Piperidines; Tromethamine | 1994 |
Topical update: new medications for ocular allergy.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Conjunctivitis, Allergic; Histamine H1 Antagonists; Humans; Ophthalmic Solutions; Oxamic Acid; Piperidines; United States; United States Food and Drug Administration | 1994 |
Effects of non-steroidal antiallergic eyedrops on the complement-mediated histamine release from human cells.
Topics: Allergens; Animals; Anti-Allergic Agents; Anti-Inflammatory Agents, Non-Steroidal; Basophil Degranulation Test; Basophils; Cell Degranulation; Complement C5; Cromolyn Sodium; Dipeptides; Enzyme-Linked Immunosorbent Assay; Histamine; Histamine H1 Antagonists; Histamine Release; Humans; Hypersensitivity, Immediate; Ophthalmic Solutions; Oxamic Acid; Piperidines; Recombinant Proteins | 1997 |
[In vitro effects of antiallergic eyedrops on complement activation induced by particulate matter].
Topics: Air Pollutants; Anti-Allergic Agents; Benzalkonium Compounds; Benzimidazoles; Complement Activation; Conjunctivitis; Cosmetics; Dibenzoxepins; Dipeptides; Drug Evaluation; Dust; Humans; In Vitro Techniques; Ketotifen; Nedocromil; Olopatadine Hydrochloride; Ophthalmic Solutions; Oxamic Acid; Phthalazines; Piperidines; Pollen; Silicon Dioxide; Zymosan | 2003 |
A CD4 mimic as an HIV entry inhibitor: pharmacokinetics.
Topics: Administration, Intravenous; Adsorption; Animals; CD4 Antigens; Half-Life; HIV Fusion Inhibitors; Macaca mulatta; Molecular Mimicry; Molecular Structure; Oxamic Acid; Piperidines; Rats; Rats, Sprague-Dawley; Surface Properties; Tissue Distribution | 2013 |
A minimally cytotoxic CD4 mimic as an HIV entry inhibitor.
Topics: Animals; CD4 Antigens; HIV Envelope Protein gp120; HIV Fusion Inhibitors; HIV Infections; HIV-1; Macaca mulatta; Molecular Docking Simulation; Oxamic Acid; Piperidines; Rats | 2016 |